Roscovitine protects murine Leydig cells from lipopolysaccharide-induced inflammation. 2017

Tiancheng Xie, and Guanghui Hu, and Binbin Dong, and Yangye Yan, and Min Liu, and Xudong Yao, and Junhua Zheng, and Yunfei Xu
Department of Urology, Shanghai Tenth People's Hospital, Tongji University, School of Medicine, Shanghai 200072, P.R. China.

Roscovitine is a cyclin-dependent kinase inhibitor, which has been previously investigated for its anticancer effects. It has also been confirmed that roscovitine can downregulate the expression of myeloid cell leukemia-1 protein to inhibit inflammation. In the present study, roscovitine was used to treat inflammation in lipopolysaccharide (LPS)-induced model mice. At the cellular level, Leydig cells isolated from mouse testis were assessed for inflammatory factors. It was revealed that roscovitine successfully reduced inflammation-associated injury induced by LPS pretreatment. At the molecular level, roscovitine was found to exert this effect through promotion of adenosine monophosphate-activated protein kinase phosphorylation. To the best of our knowledge, the present study was the first to suggest that roscovitine has a protective role in Leydig cells through its anti-inflammatory action.

UI MeSH Term Description Entries

Related Publications

Tiancheng Xie, and Guanghui Hu, and Binbin Dong, and Yangye Yan, and Min Liu, and Xudong Yao, and Junhua Zheng, and Yunfei Xu
November 2019, Antioxidants (Basel, Switzerland),
Tiancheng Xie, and Guanghui Hu, and Binbin Dong, and Yangye Yan, and Min Liu, and Xudong Yao, and Junhua Zheng, and Yunfei Xu
September 2018, Current eye research,
Tiancheng Xie, and Guanghui Hu, and Binbin Dong, and Yangye Yan, and Min Liu, and Xudong Yao, and Junhua Zheng, and Yunfei Xu
January 2016, Mediators of inflammation,
Tiancheng Xie, and Guanghui Hu, and Binbin Dong, and Yangye Yan, and Min Liu, and Xudong Yao, and Junhua Zheng, and Yunfei Xu
December 2017, Brazilian journal of medical and biological research = Revista brasileira de pesquisas medicas e biologicas,
Tiancheng Xie, and Guanghui Hu, and Binbin Dong, and Yangye Yan, and Min Liu, and Xudong Yao, and Junhua Zheng, and Yunfei Xu
December 2022, Reproduction in domestic animals = Zuchthygiene,
Tiancheng Xie, and Guanghui Hu, and Binbin Dong, and Yangye Yan, and Min Liu, and Xudong Yao, and Junhua Zheng, and Yunfei Xu
January 2018, Toxicology and applied pharmacology,
Tiancheng Xie, and Guanghui Hu, and Binbin Dong, and Yangye Yan, and Min Liu, and Xudong Yao, and Junhua Zheng, and Yunfei Xu
June 2021, Marine drugs,
Tiancheng Xie, and Guanghui Hu, and Binbin Dong, and Yangye Yan, and Min Liu, and Xudong Yao, and Junhua Zheng, and Yunfei Xu
February 2015, Experimental and therapeutic medicine,
Tiancheng Xie, and Guanghui Hu, and Binbin Dong, and Yangye Yan, and Min Liu, and Xudong Yao, and Junhua Zheng, and Yunfei Xu
July 2012, CNS neuroscience & therapeutics,
Tiancheng Xie, and Guanghui Hu, and Binbin Dong, and Yangye Yan, and Min Liu, and Xudong Yao, and Junhua Zheng, and Yunfei Xu
January 2012, Evidence-based complementary and alternative medicine : eCAM,
Copied contents to your clipboard!